Newsletter Advisors.com

   

  Growth Report: As China's Milk Consumption Soars, American Dairy Profits

Get the current edition now. It's Free!
 

 


By Ian Wyatt
Growth Report, Winter '07
American Dairy (ADY)

China’s market for dairy products is at an early stage and poised for stellar growth. The country’s current dairy consumption stands only at about a fifth of the world average, according to the Ministry of Agriculture in China, but the People’s Republic of China (PRC) aims to change this as there is a clear governmental push to promote the drinking of milk as part of a healthier diet.

“I have a dream to provide every Chinese, especially children, sufficient milk each day,” said Chinese Premier Wen Jiabao in April of 2006. Currently in place are government subsidy programs for school children along with state-run educational TV programs that promote the benefits of drinking milk. And given that there are about 200 million primary school children in China, growth potential is sizeable.

The PRC’s put its money where its mouth is too, with programs to grow the Chinese dairy industry including exemption from corporate income tax and Value Added Tax (VAT) rebates.

American Dairy (NYSE: ADY) is a small-cap Chinese stock clearly benefiting from this push, and provides investors with the opportunity for impressive growth given the expanding market and attractive valuation. The company’s wholly owned subsidiary, Feihe Dairy, is a growing producer and distributor of milk powder and soybean products in China. Among the firm’s merits are modern processing facilities, good sourcing of raw milk, strong brand recognition, established distribution networks, and continued product development and diversification.

Strategically situated in the key “Milk Belt” of Northeastern China, American Dairy is close to its network of milk suppliers, a critical factor given the competition for raw milk in the country. Helping to drive growth is the company’s focus on quality and brand recognition.

The company estimates that around 68% of revenues this year will be derived from the production of milk powder with the remaining from soybean and walnut-based products. Another positive is the company’s strategy to focus on higher margin products such as infant formula, yogurt and cheese products to satisfy rising demand.

American Dairy experienced significant growth in 2005. Revenue for the year was $68 million, an increase of 82% from $37.4 million the previous year. Net income was $11.6 million, or $0.74 per share, an increase of 78.5% from $6.5 million, or $0.47, in 2004.

In the second quarter of 2006, revenue grew 72% to $26.1 million from $15.1 million in the year ago quarter. Growth in the company’s infant formula and milk powder products drove the revenue growth. Second quarter earnings surged 86% to $5.3 million, or $0.31 per diluted share from $2.8 million, or $0.18 per diluted share in the year ago quarter.

As part of its growth strategy, American Dairy aims to expand sales of its products to contiguous markets across China with high population density. The company said it would also enter into other markets via joint ventures, licensing, or arrangements with local farmers. Key objectives of this growth strategy include expanding its customer base via the selling of fluid milk products in no-return containers and increasing sales of higher margin solid milk products such as yogurt and cheese.

Looking ahead, American Dairy is estimated to earn $1.18 per diluted share on revenues of $120.17 million in 2006, up 59.5% and 76.7%, respectively, from 2005, according to a single estimate by Westminster Securities. The earnings estimate gives the stock an attractive valuation of 12.3X its estimated FY06 EPS.

With shares of American Dairy down about 30% from its 52-week high of $19.98, the current price and valuation look attractive for growth-oriented investors looking for a solid Chinese growth company. We believe the shares could trade significantly higher in the next twelve months and expect that shares will trade at $18.00 in the next month, translating into an extremely conservative 15X the FY06 estimate of $1.18 and 18X trailing 12 month EPS. This represents a 28.6% increase from the current price of $14.00. We would be buyers of the stock at the current share price.

 
This Article is from the Winter 2007 Top 10 Special Report. Get the latest stock recommendations from other top financial experts today!  Request your FREE copy of the newest report from NewsletterAdvisors.com.  Click here.